Company

Solaris Endovascular, Inc.

Solaris Endovascular develops stent grafts for dialysis access complications and peripheral artery disease.

About

Solaris Endovascular develops covered stents, including Solaris SX and Solaris DE, for dialysis access and peripheral artery disease. Founded in 2024 and based in Dallas, US, it raised USD 5.00 mn from UTI Ventures in July 2026 to advance Solaris DE toward commercialization. The company has sold over 13,000 units and markets products in Europe, Asia and parts of North America.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in